The use of oxygen and prostacyclin as pulmonary vasodilators in congenital heart disease
- 1 November 1985
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 9 (3) , 267-274
- https://doi.org/10.1016/0167-5273(85)90024-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Pulmonary vascular resistance in children with congenital heart disease.Thorax, 1984
- Clinical problems of postoperative pulmonary vascular diseaseThe American Journal of Cardiology, 1982
- Prostacyclin Infusion in Hypertension: Acute Hemodynamic and Hormonal EffectsNew England Journal of Medicine, 1982
- Pulmonary vascular disease with congenital heart lesions: pathologic features and causes.Circulation, 1981
- Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.Circulation, 1981
- PROSTACYCLIN: HAEMODYNAMIC AND METABOLIC EFFECTS IN PATIENTS WITH CORONARY ARTERY DISEASEThe Lancet, 1981
- Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat.Circulation Research, 1979
- Generation of prostacyclin by lungs in vivo and its release into the arterial circulationNature, 1978
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Neonatal hypoxia and pulmonary vasospasm: Response to tolazolineThe Journal of Pediatrics, 1976